HeartLogic Remote Monitoring Trial Heart Failure Apr 22
ClinicalTrials.gov Studies
Summary
A randomized, multicenter clinical trial has been registered on ClinicalTrials.gov under NCT07544771 to evaluate whether HeartLogic™ algorithm-guided remote management improves outcomes versus traditional face-to-face follow-up in adult heart failure patients recently implanted with a HeartLogic™-enabled ICD or CRT-D device. The primary endpoint at 12 months is a composite of death, unscheduled hospitalization for heart failure, or quality-of-life deterioration. Secondary endpoints include hospitalization, mortality, quality of life, safety, and cost-effectiveness. This is an interventional study with alert-guided remote follow-up as the active intervention and traditional follow-up as the comparator.
“This randomized, multicenter clinical trial will evaluate whether remote management guided by the HeartLogic™ algorithm improves outcomes compared with traditional face-to-face follow-up in adult patients with heart failure recently implanted with a HeartLogic™-enabled ICD or CRT-D device.”
About this source
GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 734 changes logged to date.
What changed
A randomized, multicenter clinical trial evaluating HeartLogic™ algorithm-guided remote management against traditional face-to-face follow-up in adult patients with heart failure implanted with HeartLogic™-enabled ICD or CRT-D devices has been registered on ClinicalTrials.gov. The primary objective is to determine whether remote management reduces a composite of death, unscheduled heart-failure hospitalization, or quality-of-life deterioration at 12 months. Secondary objectives include hospitalization, mortality, quality of life, safety, and cost-effectiveness assessments.
Healthcare providers and clinical investigators involved in heart-failure device management may benefit from awareness of this trial's design and endpoints, particularly those assessing whether alert-guided remote follow-up can safely replace or supplement in-office visits for patients with implanted cardiac devices. The trial's cost-effectiveness secondary endpoint may also be of interest to payers and health-system administrators evaluating remote monitoring programs.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HeartLogic™ in Patients With Heart Failure.
N/A NCT07544771 Kind: NA Apr 22, 2026
Abstract
This randomized, multicenter clinical trial will evaluate whether remote management guided by the HeartLogic™ algorithm improves outcomes compared with traditional face-to-face follow-up in adult patients with heart failure recently implanted with a HeartLogic™-enabled ICD or CRT-D device. The primary objective is to determine whether this strategy reduces, at 12 months, the proportion of patients with death, unscheduled hospitalization for heart failure, or deterioration in quality of life. Secondary objectives include assessment of hospitalization, mortality, quality of life, safety, and cost-effectiveness.
Conditions: Heart Failure
Interventions: Alert-guided remote follow-up, Traditional follow up
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.